FULL-LENGTH ORIGINAL RESEARCH
A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage
Version of Record online: 9 DEC 2011
Wiley Periodicals, Inc. © 2011 International League Against Epilepsy
Volume 53, Issue 1, pages 134–146, January 2012
How to Cite
White, H. S., Alex, A. B., Pollock, A., Hen, N., Shekh-Ahmad, T., Wilcox, K. S., McDonough, J. H., Stables, J. P., Kaufmann, D., Yagen, B. and Bialer, M. (2012), A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. Epilepsia, 53: 134–146. doi: 10.1111/j.1528-1167.2011.03338.x
- Issue online: 4 JAN 2012
- Version of Record online: 9 DEC 2011
- Accepted October 17, 2011; Early View publication December 9, 2011.
Vol. 53, Issue 2, 397, Version of Record online: 26 JAN 2012
Data S1. Experimental section: Materials and methods.
Figure S1. Plasma concentration-time plot obtained following intraperitoneal administration of SPD (60 mg/kg) to rats.
Table S1. Effect of SPD on the threshold for minimal seizures induced by the timed intravenous infusion of Metrazol in mice following intraperitoneal administration.
|EPI_3338_sm_SI.doc||113K||Supporting info item|
|EPI_3338_sm_FigS1.tif||108K||Supporting info item|
|EPI_3338_sm_Support-Infrev.doc||104K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.